Prolight receives new patent approval in the US

The United States Patent and Trademark Office has granted a patent covering the composition of matter of ATOR-4066, the company’s bispecific antibody targeting CD40 and CEACAM5.

Neogap Therapeutics has been granted a Chinese patent for its method of expanding tumour-specific T cells – a key component of the company’s therapeutic approach.

The company has been granted patent approval by the Japan Patent Office (JPO) concerning the automatic control of Realheart TAH.

The company has announced that the ongoing patent application for the iTANK platform in the United States is still under examination by the United States Patent and Trademark Office (USPTO).

Faron Pharmaceuticals has announced that the United States Patent and Trademark Office has granted a new US Patent for treatment of Clever-1 positive cancers with bexmarilimab and related structures that would bind to Clever-1 molecule for the wanted re-programming effect.

VibroSense Dynamics has received an Intention to Grant from the European Patent Office (EPO) regarding a patent on a biomarker to predict the risk of developing permanent nerve damage after cancer treatment with chemotherapy.

The United States Patent and Trademark Office (USPTO) has granted a patent in the US covering the use of Mendus’ lead product vididencel in ovarian cancer.